{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T08:48:48Z","timestamp":1648802928552},"reference-count":42,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.neurol.2012.09.002","type":"journal-article","created":{"date-parts":[[2012,10,26]],"date-time":"2012-10-26T21:31:33Z","timestamp":1351287093000},"page":"975-978","source":"Crossref","is-referenced-by-count":0,"title":["Revue de la litt\u00e9rature 2011\u00a0: neuropathies dysimmunitaires"],"prefix":"10.1016","volume":"168","author":[{"given":"T.","family":"Kuntzer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurol.2012.09.002_bib0005","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00234-010-0684-7","article-title":"Brachial and lumbar plexuses in chronic inflammatory demyelinating polyradiculoneuropathy: MRI assessment including apparent diffusion coefficient","volume":"53","author":"Adachi","year":"2011","journal-title":"Neuroradiology"},{"key":"10.1016\/j.neurol.2012.09.002_bib0010","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/mus.22024","article-title":"Response to treatment in patients with Lewis-Sumner syndrome","volume":"44","author":"Attarian","year":"2011","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.neurol.2012.09.002_bib0015","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1136\/jnnp.2009.188912","article-title":"Rituximab in patients with chronic inflammatory demyelinating polyradiculoneuropathy: a report of 13\u00a0cases and review of the literature","volume":"82","author":"Benedetti","year":"2011","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2012.09.002_bib0020","doi-asserted-by":"crossref","first-page":"E179","DOI":"10.3174\/ajnr.A2754","article-title":"Thickening and contrast enhancement of spinal roots on MR imaging in Guillain-Barre syndrome: thoughts on pathologic background","volume":"32","author":"Berciano","year":"2011","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.neurol.2012.09.002_bib0025","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1529-8027.2011.00298.x","article-title":"Current diagnosis of CIDP: the need for biomarkers","volume":"16","author":"Brannagan","year":"2011","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.neurol.2012.09.002_bib0030","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/mus.22038","article-title":"Review of the evolution of electrodiagnostic criteria for chronic inflammatory demyelinating polyradicoloneuropathy","volume":"43","author":"Bromberg","year":"2011","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.neurol.2012.09.002_bib0035","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1529-8027.2011.00341.x","article-title":"Home-based IVIg treatment is convenient and time-saving in patients with multifocal motor neuropathy","volume":"16","author":"Cats","year":"2011","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.neurol.2012.09.002_bib0040","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1007\/s00415-011-6042-9","article-title":"Preceding infections and anti-ganglioside antibody profiles assessed by a dot immunoassay in 306\u00a0French Guillain-Barre syndrome patients","volume":"258","author":"Caudie","year":"2011","journal-title":"J Neurol"},{"key":"10.1016\/j.neurol.2012.09.002_bib0045","doi-asserted-by":"crossref","first-page":"e14533","DOI":"10.1371\/journal.pone.0014533","article-title":"Nodes of ranvier and paranodes in chronic acquired neuropathies","volume":"6","author":"Cifuentes-Diaz","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.neurol.2012.09.002_bib0050","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1111\/j.1468-1331.2011.03495.x","article-title":"Immunosuppressive treatment in refractory chronic inflammatory demyelinating polyradiculoneuropathy. A nationwide retrospective analysis","volume":"18","author":"Cocito","year":"2011","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.neurol.2012.09.002_bib0055","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1529-8027.2011.00340.x","article-title":"The efficacy of subcutaneous immunoglobulin administration in chronic inflammatory demyelinating polyneuropathy responders to intravenous immunoglobulin","volume":"16","author":"Cocito","year":"2011","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.neurol.2012.09.002_bib0060","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1212\/WNL.0b013e318207b1f6","article-title":"Evidence-based guideline update: plasmapheresis in neurologic disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology","volume":"76","author":"Cortese","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2012.09.002_bib0065","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nrneurol.2011.121","article-title":"Advances in the diagnosis, pathogenesis and treatment of CIDP","volume":"7","author":"Dalakas","year":"2011","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.neurol.2012.09.002_bib0070","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1136\/jnnp.2010.226639","article-title":"Guillain-Barre syndrome subtypes related to Campylobacter infection","volume":"82","author":"Drenthen","year":"2011","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2012.09.002_bib0075","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1529-8027.2011.00328.x","article-title":"An open label clinical trial of complement inhibition in multifocal motor neuropathy","volume":"16","author":"Fitzpatrick","year":"2011","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.neurol.2012.09.002_bib0080","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1529-8027.2010.00284.x","article-title":"Chronic inflammatory demyelinating polyneuropathy disease activity status: recommendations for clinical research standards and use in clinical practice","volume":"15","author":"Gorson","year":"2011","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.neurol.2012.09.002_bib0085","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1529-8027.2011.00334.x","article-title":"Novel treatment for immune neuropathies on the horizon","volume":"16","author":"Hartung","year":"2011","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.neurol.2012.09.002_bib0090","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/nrneurol.2011.46","article-title":"Peripheral neuropathies: establishing common clinical research standards for CIDP","volume":"7","author":"Hartung","year":"2011","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.neurol.2012.09.002_bib0095","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.neurol.2011.08.001","article-title":"New concepts in paraneoplastic neurological syndromes","volume":"167","author":"Honnorat","year":"2011","journal-title":"Rev Neurol (Paris)"},{"key":"10.1016\/j.neurol.2012.09.002_bib0100","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD008630.pub2","article-title":"Pharmacological treatment other than corticosteroids, intravenous immunoglobulin and plasma exchange for Guillain Barre syndrome","author":"Hughes","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.neurol.2012.09.002_bib0105","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jneuroim.2011.08.016","article-title":"Antibodies to LM1\u00a0and LM1-containing ganglioside complexes in Guillain-Barre syndrome and chronic inflammatory demyelinating polyneuropathy","volume":"239","author":"Kuwahara","year":"2011","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.neurol.2012.09.002_bib0110","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1001\/archneurol.2011.47","article-title":"Cytokines in Guillain-Barre syndrome: a lesson in time","volume":"68","author":"Lambracht-Washington","year":"2011","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neurol.2012.09.002_bib0115","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/j.1468-1331.2010.03312.x","article-title":"Non-anti-MAG DADS neuropathy as a variant of CIDP: clinical, electrophysiological, laboratory features and response to treatment in 10\u00a0cases","volume":"18","author":"Larue","year":"2011","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.neurol.2012.09.002_bib0120","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1529-8027.2011.00299.x","article-title":"Biomarkers of CIDP in patients with diabetes or CMT1","volume":"16","author":"Latov","year":"2011","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.neurol.2012.09.002_bib0125","doi-asserted-by":"crossref","first-page":"E140","DOI":"10.3174\/ajnr.A2620","article-title":"The diagnostic, prognostic, and differential value of enhanced MR imaging in Guillain-Barre syndrome","volume":"32","author":"Li","year":"2011","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.neurol.2012.09.002_bib0130","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1093\/brain\/awq119","article-title":"Anti-GD1a antibodies activate complement and calpain to injure distal motor nodes of Ranvier in mice","volume":"133","author":"McGonigal","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2012.09.002_bib0135","doi-asserted-by":"crossref","first-page":"e21223","DOI":"10.1371\/journal.pone.0021223","article-title":"Quinpramine ameliorates rat experimental autoimmune neuritis and redistributes MHC class II molecules","volume":"6","author":"Meyer zu","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.neurol.2012.09.002_bib0140","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1529-8027.2011.00330.x","article-title":"A smooth transition protocol for patients with multifocal motor neuropathy going from intravenous to subcutaneous immunoglobulin therapy: an open-label proof-of-concept study","volume":"16","author":"Misbah","year":"2011","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.neurol.2012.09.002_bib0145","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1529-8027.2011.00300.x","article-title":"Testing for anti-glycolipid IgM antibodies in chronic immune-mediated demyelinating neuropathies","volume":"16","author":"Nobile-Orazio","year":"2011","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.neurol.2012.09.002_bib0150","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1001\/archneurol.2011.51","article-title":"TH1\u00a0and TH2\u00a0response to Campylobacter jejuni antigen in Guillain-Barre syndrome","volume":"68","author":"Nyati","year":"2011","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neurol.2012.09.002_bib0155","doi-asserted-by":"crossref","first-page":"e173","DOI":"10.1093\/brain\/awq372","article-title":"Neurofascin as target of autoantibodies in Guillain-Barre syndrome","volume":"134","author":"Pruss","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2012.09.002_bib0160","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/ana.22110","article-title":"Motor nerve biopsy: clinical usefulness and histopathological criteria","volume":"69","author":"Riva","year":"2011","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2012.09.002_bib0165","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1136\/jnnp-2011-300309","article-title":"Antiganglioside antibodies are associated with axonal Guillain-Barr\u00e9 syndrome: a Japanese \u2013 Italian collaborative study","volume":"83","author":"Sekiguchi","year":"2012","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2012.09.002_bib0170","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1529-8027.2011.00301.x","article-title":"Nerve biopsy in chronic inflammatory neuropathies: in situ biomarkers","volume":"16","author":"Sommer","year":"2011","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.neurol.2012.09.002_bib0175","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1529-8027.2011.00302.x","article-title":"Differential gene expression in nerve biopsies of inflammatory neuropathies","volume":"16","author":"Steck","year":"2011","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.neurol.2012.09.002_bib0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jns.2011.05.010","article-title":"Drug-induced dysimmune demyelinating neuropathies","volume":"307","author":"Stubgen","year":"2011","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.neurol.2012.09.002_bib0185","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.3174\/ajnr.A2257","article-title":"High-resolution MR neurography of diffuse peripheral nerve lesions","volume":"32","author":"Thawait","year":"2011","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.neurol.2012.09.002_bib0190","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1529-8027.2011.00339.x","article-title":"Screening for antecedent Campylobacter jejuni infections and anti-ganglioside antibodies in idiopathic neuralgic amyotrophy","volume":"16","author":"van Eijk","year":"2011","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.neurol.2012.09.002_bib0195","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1212\/WNL.0b013e318208824b","article-title":"Rasch-built Overall Disability Scale (R-ODS) for immune-mediated peripheral neuropathies","volume":"76","author":"van Nes","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2012.09.002_bib0200","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1517\/14728214.2011.531699","article-title":"Emerging drugs for Guillain-Barre syndrome","volume":"16","author":"Walgaard","year":"2011","journal-title":"Expert Opin Emerg Drugs"},{"key":"10.1016\/j.neurol.2012.09.002_bib0205","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1212\/WNL.0b013e3182104407","article-title":"Early recognition of poor prognosis in Guillain-Barre syndrome","volume":"76","author":"Walgaard","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2012.09.002_bib0210","doi-asserted-by":"crossref","first-page":"639","DOI":"10.3174\/ajnr.A2358","article-title":"Redefining the Guillain-Barre spectrum in children: neuroimaging findings of cranial nerve involvement","volume":"32","author":"Zuccoli","year":"2011","journal-title":"AJNR Am J Neuroradiol"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378712009824?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378712009824?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T13:22:30Z","timestamp":1584019350000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0035378712009824"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":42,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S0035378712009824"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2012.09.002","relation":{},"ISSN":["0035-3787"],"issn-type":[{"value":"0035-3787","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}